Cardiotube Interview: LBCT: Outcomes Of Patients Who Were Ineligible For Transcatheter Mitral Valve Replacement Trials: Insight From A Multicenter Registry

Sunday, March 8, 2026

1:45 PM - 2:00 PM EST

Location: Lobby Level - Next to Speaker Ready

Interviewer(s)

Daniel H. Steinberg, MD

Professor of Medicine and Surgery
Medical University of South Carolina
Charleston, South Carolina, United States

Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

Interviewee(s)

Anas I. Zaqut, Medical Doctor

Postdoctoral Research Fellow
Oregon Health and Science University

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Daniel H. Steinberg, MD: Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

Anas I. Zaqut, Medical Doctor: No financial relationships to disclose